Federal officials said Medicare should limit coverage of an unproven Alzheimer’s drug responsible in part for the hike.
The reactionary “justices” seem more inclined to shield corporate profits than to protect people’s health and safety.
The FDA has faced sharp criticism for approving Aduhelm even though clinical trials exposed serious safety risks.
Help with parenting, according to state and federal law, is not covered under current Medicare rules.
COVID “really illustrated just how dysfunctional the system actually is,” said one survey respondent.
Advocates in West Virginia have called out their senator for opposing adding dental coverage for Medicare recipients.
Aduhelm, approved by the FDA in June despite much pushback, is expected to be a huge burden on the health care system.
30 million seniors who thought they were free of insurance companies may find their health care managed by corporations.
The Medicare experiment could result in health care policy and political nightmare, but most in Congress seem unaware.
A new poll shows the public is unified on lower drug prices, but pharma campaign cash is keeping legislation in check.